120 related articles for article (PubMed ID: 25939703)
21. Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation.
Zheng F; Li H; Du W; Huang S
Hematology; 2011 May; 16(3):177-84. PubMed ID: 21669058
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.
Xu Z; Zeng X; Tian D; Xu H; Cai Q; Wang J; Chen Q
Biochem Biophys Res Commun; 2014 Oct; 453(4):833-8. PubMed ID: 25450356
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1.
Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y
Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705
[TBL] [Abstract][Full Text] [Related]
24. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
[TBL] [Abstract][Full Text] [Related]
25. H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma.
Chen S; Chen J; Zhan Q; Zhu Y; Chen H; Deng X; Hou Z; Shen B; Chen Y; Peng C
Oncotarget; 2014 Nov; 5(21):10421-33. PubMed ID: 25431952
[TBL] [Abstract][Full Text] [Related]
26. WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation.
Deng G; Li ZQ; Zhao C; Yuan Y; Niu CC; Zhao C; Pan J; Si WK
Oncol Rep; 2011 Feb; 25(2):367-76. PubMed ID: 21165581
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
[TBL] [Abstract][Full Text] [Related]
29. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.
Guo X; Zhang R; Liu J; Li M; Song C; Dovat S; Li J; Ge Z
PLoS One; 2015; 10(5):e0125429. PubMed ID: 25942645
[TBL] [Abstract][Full Text] [Related]
30. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
31. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
32. SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.
Yang Q; Wang B; Gao W; Huang S; Liu Z; Li W; Jia J
Mol Cancer Res; 2013 Dec; 11(12):1497-507. PubMed ID: 24107295
[TBL] [Abstract][Full Text] [Related]
33. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.
Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC
Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625
[TBL] [Abstract][Full Text] [Related]
34. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.
Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Sola B; Roué G
Clin Cancer Res; 2014 Jan; 20(2):393-403. PubMed ID: 24178620
[TBL] [Abstract][Full Text] [Related]
35. BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma.
Rouhigharabaei L; Ferreiro JF; Put N; Michaux L; Tousseyn T; Lefebvre C; Gardiner A; De Kelver W; Demuynck H; Verschuere J; Théate I; Vicente C; Vandenberghe P; Cools J; Wlodarska I
Genes Chromosomes Cancer; 2013 Oct; 52(10):928-44. PubMed ID: 23873701
[TBL] [Abstract][Full Text] [Related]
36. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
37. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
38. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
[TBL] [Abstract][Full Text] [Related]
39. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif.
Luo Y; Hao Y; Shi TP; Deng WW; Li N
Acta Pharmacol Sin; 2008 May; 29(5):628-33. PubMed ID: 18430372
[TBL] [Abstract][Full Text] [Related]
40. [Regulatory mechanisms of PI3K/AKT signaling pathway in acute leukemia].
Wang WL; Zhang YC; Zeng HM; Hua CL; Wei W; Xu J; Zhu XF; Cheng T; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):18-21. PubMed ID: 22391157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]